However, genome-scale CRISPR-Cas9 knockout screens showed that LAMA5 depletion resulted in nearly zero in almost all types of cancers, suggesting LAMA5 was not required for tumor cell survival (Supplementary Fig. S10C). This evidence concerns the gene LAMA5 and neoplasm.